Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Verde Science Inc VRCI

Verde Science, Inc. is a pharmaceutical research and development company. The Company is engaged in medical science consulting business. The Company is focused on the discovery of drugs and treatment modalities, as well as diagnostic devices and pharmaceutical delivery systems for the treatment of diseases and medical issues. The Company is focused on developing medicinal formulations from... see more

GREY:VRCI - Post Discussion

Verde Science Inc > Evergreen-Agra Inc
View:
Post by 8saturday8 on Dec 03, 2013 10:22am

Evergreen-Agra Inc

I just want to remind everyone that Harp is the Chairman of the board of this company. It has 823,000 shares out. The last price was $2.05 a share. It has not traded for a while. But from what I can tell it has solid backing and no properties right now. I do not know what is in back of Harps mind but it looks to me like he is trying hard to make a very big company. Maybe he wants to J.V  Evergreen with Rango or consolidate them into one big company. Who knows. Harp is a deal guy.
Comment by ootobee on Dec 10, 2013 10:01am
Do people actually read the financial statements for these companies before commenting on them? The financials filed for Evergreen-Agra in October 2013 show assets of just over $6,000 and liabilities of almost $1,6 million.  It's made a loss since inception of approximately $7,5 million with no revenues whatsoever. It's moved from being some kind of pharmaceutical company to a mining ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities